Month: July 2019
-
Protein-Eluding Scaffolds Help Grow New Blood Vessels
A polymer frame infused with proteins that stimulate immune cells encourages growth of new blood vessels in lab mice with peripheral artery disease.
-
Once-a-Month Contraceptive Pill Being Developed
A company specializing in long-term release of drugs is receiving a foundation grant to develop a contraceptive pill for women that works for weeks at a time.
-
How a High Precision Battery Test Can Aid Electrochemical R&D
A battery impedance tester is a vital piece of equipment that is most frequently used in businesses where downtime would be costly and have a significant, negative impact on operations.
-
Taking a Break
We’re taking a few days off at Science & Enterprise, for some study-travel and book reading. We’ll be back at the end of July.
-
Infographic – U.S. Venture Funds Near 20-Year Highs
Total venture capital funding in the U.S. for first six months of 2019 reached levels not seen since the year 2000, the waning days of the dot-com era.
-
A.I. Helps Visualize Emergency Social Media Data
A set of computational tools developed at Purdue University enables public safety agencies to monitor potentially catastrophic events in real time by analyzing text and images on social media.
-
Hearing Loss Cell Therapy Licensed in $625M Deal
A biotechnology company developing regenerative treatments for various disorders is licensing its lead therapy candidate for hearing loss to Astellas Pharma.
-
Top 5 Government Contract Financing Options for You
Small business owners often encounter problems due to lack of funding needed to fulfill government contracts, causing them to fail.
-
Smart Fabrics Boost Wearable Sensor Connections
A new type of smart fabric can dramatically improve connectivity between wearable sensors and mobile devices compared to current wireless networks.
-
Genentech, Biotech Partner on Multiple Sclerosis
A company designing treatments to restore the protective coating on nerve cells damaged by multiple sclerosis is collaborating with biotechnology enterprise Genentech.